Globally, NB.1.8.1 is now the dominant variant. The WHO has issued a warning about rising COVID-19 activity in the Western Pacific, Southeast Asia, and Eastern Mediterranean, driven by NB.1.8.1 this week.
H/T: @RajlabN
Classified as a "variant under monitoring" by the WHO & “ Nimbus” by @TRyanGregory, NB.1.8.1 has triggered a seventh consecutive week of surges in Southeast Asia. Taiwan has seen ER visits double again this week. 2/
@TRyanGregory China is reporting widespread infections with NB.1.8.1 causing severe throat pain described as “razor blade throat.”
However, the #Nimbus aka NB.1.8.1 wave in Hong Kong and Singapore may have peaked. 3/
@TRyanGregory A new surge is going on in India too. Still early days…active Covid-19 cases have risen to 3,758, with Kerala reporting the highest at 1,400 cases.
One death is also reported from my own district though no uptick is noticed in children so far. 4/4
@TRyanGregory Last year’s Fall 2024 COVID vaccine targeted KP.2 for Moderna/Pfizer & JN.1 for Novavax. Although FDA’s advisory panel favored sticking with JN.1-based strains for Fall 2025, they agreed LP.8.1 is an appropriate alternative for 2025/2026 season 6/
No JN.1/adapted booster
The only Omicron-adapted vax is Gemcovac-OM based on BA.1
Even this isn’t freely available
The only category who need boosters in India: elderly w/ comorbidities or immunocompromised
So what’s the recs for Covid vax here👇 7/7
• • •
Missing some Tweet in this thread? You can try to
force a refresh
New research finds that SARS-CoV-2 spike protein can persist in the gut of people with #LongCOVID, even months after infection.
➡️ This persistent viral antigen may drive ongoing immune changes in intestinal tissue.
➡️ Scientists detected viral spike RNA and protein in colon and ileum biopsies from Long COVID patients.
➡️ In these regions, genes linked to inflammation, immune dysfunction, and tissue stress were altered. 1/
Persistent spike-positive areas in the colon showed increased immune cell activity, including:
• Macrophages
• Plasma cells
• Regulatory T cells
Suggesting an active local immune response in the gut.
➡️ Researchers also found disrupted expression of key immune-signaling genes, indicating impaired immune coordination and chronic inflammation in gut tissues. 2/
SARS-CoV-2 persistence is a proposed driver of Long COVID (LC), but the in-situ relationship between residual viral antigen and immune dysregulation remains poorly defined.
➡️ This NEW study provides robust evidence that persistent SARS-CoV-2 Spike protein detection in the gut is not immunologically inert.
➡️ Instead, it is actively associated with distinct, immune cell composition shifts and a dysfunctional pro-inflammatory transcriptional profile, supporting the hypothesis that retained viral antigen drives chronic immune dysregulation in tissue of LongCOVID subjects. 3/
A small brain-imaging study found that people with #LongCOVID showed slower thinking and reaction times during a cognitive task.
➡️ Advanced MRI scans revealed changes in how important brain networks communicate with each other, especially those involved in attention, language, and decision-making. 1/
Researchers found altered connectivity in key brain networks:
• Salience network
• Language network
• Central executive network
• Sensorimotor and visual networks
➡️ These systems are essential for attention, decision-making, and task control. 2/
The most prominent deficits were seen in the salience network, which helps the brain detect and respond to important stimuli.
➡️ Connectivity problems in this network were more severe with longer illness duration. 3/